16-3657746-G-A
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_005223.4(DNASE1):c.731G>A(p.Arg244Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.336 in 1,613,564 control chromosomes in the GnomAD database, including 100,282 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Consequence
NM_005223.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNASE1 | NM_005223.4 | c.731G>A | p.Arg244Gln | missense_variant | 8/9 | ENST00000246949.10 | NP_005214.2 | |
LOC124903631 | XR_007064954.1 | n.22C>T | non_coding_transcript_exon_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNASE1 | ENST00000246949.10 | c.731G>A | p.Arg244Gln | missense_variant | 8/9 | 1 | NM_005223.4 | ENSP00000246949 | P1 |
Frequencies
GnomAD3 genomes AF: 0.438 AC: 66596AN: 151882Hom.: 17497 Cov.: 32
GnomAD3 exomes AF: 0.360 AC: 90373AN: 251148Hom.: 18114 AF XY: 0.353 AC XY: 47976AN XY: 135776
GnomAD4 exome AF: 0.325 AC: 475727AN: 1461564Hom.: 82748 Cov.: 63 AF XY: 0.326 AC XY: 236893AN XY: 727092
GnomAD4 genome AF: 0.439 AC: 66701AN: 152000Hom.: 17534 Cov.: 32 AF XY: 0.438 AC XY: 32513AN XY: 74286
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 65% of patients studied by a panel of primary immunodeficiencies. Number of patients: 57. Only high quality variants are reported. - |
DNASE1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 21, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Systemic lupus erythematosus, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Oct 15, 2004 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at